Aveanna Healthcare (AVAH) to Release Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) will likely be posting its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, March 19, 2026 at 10:00 AM ET.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $7.42 on Thursday. Aveanna Healthcare has a 12-month low of $3.67 and a 12-month high of $10.32. The company has a market cap of $1.55 billion, a PE ratio of 20.61 and a beta of 2.07. The stock has a 50 day simple moving average of $8.19 and a 200-day simple moving average of $8.55. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on AVAH shares. William Blair started coverage on Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating for the company. Raymond James Financial reiterated an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Finally, Barclays upped their price target on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Aveanna Healthcare currently has a consensus rating of “Hold” and an average target price of $11.06.

Insider Transactions at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 18,436 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $132,923.56. Following the sale, the insider directly owned 337,755 shares in the company, valued at $2,435,213.55. The trade was a 5.18% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Edwin C. Reisz sold 60,769 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $438,144.49. Following the sale, the insider directly owned 1,447,057 shares of the company’s stock, valued at approximately $10,433,280.97. This represents a 4.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 998,595 shares of company stock valued at $7,567,770 in the last quarter. Insiders own 7.80% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of Aveanna Healthcare by 34.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the last quarter. Millennium Management LLC boosted its position in shares of Aveanna Healthcare by 1,007.1% in the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock valued at $9,107,000 after purchasing an additional 1,014,030 shares during the period. Nuveen LLC increased its stake in Aveanna Healthcare by 135.9% in the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Aveanna Healthcare by 451.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 959,488 shares of the company’s stock worth $8,511,000 after buying an additional 785,452 shares during the period. Finally, Zimmer Partners LP purchased a new stake in Aveanna Healthcare during the fourth quarter valued at about $6,189,000. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.